259 related articles for article (PubMed ID: 27705918)
1. MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.
Ho JY; Hsu RJ; Liu JM; Chen SC; Liao GS; Gao HW; Yu CP
Oncotarget; 2017 Apr; 8(14):22443-22459. PubMed ID: 27705918
[TBL] [Abstract][Full Text] [Related]
2. Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2.
Ho JY; Hsu RJ; Wu CH; Liao GS; Gao HW; Wang TH; Yu CP
Oncotarget; 2016 Aug; 7(33):53853-53868. PubMed ID: 27462780
[TBL] [Abstract][Full Text] [Related]
3. miR-532-5p promotes breast cancer proliferation and migration by targeting RERG.
Huang L; Tang X; Shi X; Su L
Exp Ther Med; 2020 Jan; 19(1):400-408. PubMed ID: 31853317
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Long Non-Coding RNA FGF14-AS2 Inhibits Colorectal Cancer Proliferation Via the RERG/Ras/ERK Signaling by Sponging microRNA-1288-3p.
Hou R; Liu Y; Su Y; Shu Z
Pathol Oncol Res; 2020 Oct; 26(4):2659-2667. PubMed ID: 32654025
[TBL] [Abstract][Full Text] [Related]
5. NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells.
Jin S; Li X; Dai Y; Li C; Wang D
Cell Oncol (Dordr); 2020 Dec; 43(6):1035-1048. PubMed ID: 32986146
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
[TBL] [Abstract][Full Text] [Related]
7. RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer.
Finlin BS; Gau CL; Murphy GA; Shao H; Kimel T; Seitz RS; Chiu YF; Botstein D; Brown PO; Der CJ; Tamanoi F; Andres DA; Perou CM
J Biol Chem; 2001 Nov; 276(45):42259-67. PubMed ID: 11533059
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
[TBL] [Abstract][Full Text] [Related]
9. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
10. Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.
Zhang X; Gao D; Fang K; Guo Z; Li L
Cancer Lett; 2019 Mar; 444():105-115. PubMed ID: 30583076
[TBL] [Abstract][Full Text] [Related]
11. MiR-125a-5p functions as a tumour suppressor in breast cancer by downregulating BAP1.
Yan L; Yu MC; Gao GL; Liang HW; Zhou XY; Zhu ZT; Zhang CY; Wang YB; Chen X
J Cell Biochem; 2018 Nov; 119(11):8773-8783. PubMed ID: 30076753
[TBL] [Abstract][Full Text] [Related]
12. Tools to study the function of the Ras-related, estrogen-regulated growth inhibitor in breast cancer.
Hanker AB; Morita S; Repasky GA; Ross DT; Seitz RS; Der CJ
Methods Enzymol; 2008; 439():53-72. PubMed ID: 18374156
[TBL] [Abstract][Full Text] [Related]
13. Characterization of RERG: an estrogen-regulated tumor suppressor gene.
Key MD; Andres DA; Der CJ; Repasky GA
Methods Enzymol; 2006; 407():513-27. PubMed ID: 16757349
[TBL] [Abstract][Full Text] [Related]
14. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
[TBL] [Abstract][Full Text] [Related]
16. ING5 suppresses breast cancer progression and is regulated by miR-24.
Cui S; Liao X; Ye C; Yin X; Liu M; Hong Y; Yu M; Liu Y; Liang H; Zhang CY; Chen X
Mol Cancer; 2017 May; 16(1):89. PubMed ID: 28490335
[TBL] [Abstract][Full Text] [Related]
17. miR-188-5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer.
Wang M; Zhang H; Yang F; Qiu R; Zhao X; Gong Z; Yu W; Zhou B; Shen B; Zhu W
J Cell Physiol; 2020 May; 235(5):4890-4901. PubMed ID: 31650530
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
20. miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG.
Zhang Y; Ren S; Yuan F; Zhang K; Fan Y; Zheng S; Gao Z; Zhao J; Mu T; Zhao S; Shang A; Li X; Jie Y
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1210-1219. PubMed ID: 29961392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
